News Detail

United Kingdom, 3 Feb 2025: The medical device industry is facing increasing regulatory scrutiny regarding the use of PVC materials containing Di(2-ethylhexyl) Phthalate (DEHP), a known endocrine disruptor. Both the FDA&rs......
View Details
Source : Henkel Ltd
PVC materials
Di(2-ethylhexyl) Phthalate (DEHP)
endocrine disruptor
thermoplastic elastomers (TPEs)
Loctite AA 3952
Loctite SI 5057
Related News
- NPPA fixes retail price of 42 formulations, revise prices based on review orders (11-02-2025)
- DCGI calls for focused interventions to enhance drug quality (11-02-2025)
- NPPA asks retailers, dealers and online pharmacies to ensure compliance of Para 24 and 25 of DPCO, 2013 (11-02-2025)
- Kerala: 12 establishments caught selling fake cosmetics, including soaps and creams, with harmful chemicals (11-02-2025)
- EMA establishes regular procedure for scientific advice on certain high-risk medical devices (11-02-2025)
- Goyal urges the pharmaceutical industry to expose those engaged in sale of counterfeit products (11-02-2025)
- WHO identifies research priorities for boosting fight against antimicrobial resistance (11-02-2025)
- Supreme Court Calls on State Officials to Address Misleading Drug Advertisements (10-02-2025)
- Cases will be initiated immediately against individuals involved in sale of intoxicants and adulteration of drugs (10-02-2025)
- An index to gauge states for drug enforcement, improve drug quality (10-02-2025)